Mediating roles of cancer stigma and resilience in the relationship between type D personality and quality of life among patients with breast cancer undergoing chemotherapy
European Journal of Oncology Nursing · 2026
DOI: 10.1016/j.ejon.2026.103122 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Oncology Nursing, 2026. Verfasst von Sujin Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Gangnam CHA Hospital, CHA University, 566 Nonhyeon-ro, Gangnam-gu, Seoul, 06135, Republic of Korea. Electronic address: sujin2…. Hauptthemen laut MEDLINE: Breast Neoplasms, Quality of Life, Resilience, Psychological, Type D Personality. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: To determine the statistically mediating roles of cancer stigma and resilience in the relationship between Type D personality and quality of life (QoL) in patients with breast cancer undergoing chemotherapy. METHODS: This cross-sectional correlational study included 129 inpatients with breast cancer recruited from a university hospital-affiliated cancer center ward. Participants completed questionnaires assessing their Type D personality, cancer stigma, resilience, and QoL. Data were analyzed using Pearson's correlation, hierarchical regression, and PROCESS Macro-mediation analysis (Model 4, 50,000 bootstrap samples). RESULTS: Type D personality negatively correlated with resilience (r = -0.493, p < 0.001) and QoL (r = -0.407, p < 0.001) and positively correlated with cancer stigma (r = 0.387, p < 0.001). Cancer stigma negatively correlated with resilience (r = -0.257, p = 0.003) and QoL (r = -0.455, p < 0.001). Meanwhile, resilience was positively associated with QoL (r = 0.514, p < 0.001). Regression analysis showed that cancer stigma and resilience significantly predicted QoL (β = -0.305, p < 0.001; β = 0.326, p < 0.001), accounting for 26.4% of the variance. Bootstrapped mediation analysis indicated that cancer stigma and resilience explained the link between type D personality and QoL (B = -0.0128, 95% BootCI [-0.0194, -0.0070]). Two significant indirect pathways between type D personality and QoL were identified: perceived cancer stigma (B = -0.0058, 95% BootCI [-0.0104, -0.0018]) and resilience (B = -0.0070, 95% BootCI [-0.0130, -0.0025]). CONCLUSION: Reducing cancer stigma and enhancing resilience may help improve QoL among patients with breast cancer receiving chemotherapy, particularly those with Type D personality. These findings underscore the importance of targeted psychosocial nursing interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Gangnam CHA Hospital, CHA University, 566 Nonhyeon-ro, Gangnam-gu, Seoul, 06135, Republic of Korea. Electronic address: sujin2188@chamc.co.kr.
- College of Nursing, CHA University, 120 Haeryong-ro, Pocheon-si, Gyeonggi-do, 11160, Republic of Korea. Electronic address: sunki@cha.ac.kr.
- College of Nursing, CHA University, 120 Haeryong-ro, Pocheon-si, Gyeonggi-do, 11160, Republic of Korea. Electronic address: clara@cha.ac.kr.
Zitieren
APA
Kim, S., Kim, S., & Park, H. J. (2026). Mediating roles of cancer stigma and resilience in the relationship between type D personality and quality of life among patients with breast cancer undergoing chemotherapy. European Journal of Oncology Nursing. https://doi.org/10.1016/j.ejon.2026.103122
Vancouver
Kim S, Kim S, Park HJ. Mediating roles of cancer stigma and resilience in the relationship between type D personality and quality of life among patients with breast cancer undergoing chemotherapy. European Journal of Oncology Nursing. 2026. doi:10.1016/j.ejon.2026.103122
BibTeX
@article{Kim2026,
author = {Kim, Sujin and Kim, Sunki and Park, Hye-Ja},
title = {Mediating roles of cancer stigma and resilience in the relationship between type D personality and quality of life among patients with breast cancer undergoing chemotherapy},
journal = {European Journal of Oncology Nursing},
year = {2026},
doi = {10.1016/j.ejon.2026.103122}
}
EUVIMED